Market Research Logo

Global Meningococcal Vaccines Market 2016-2020

About Meningitis

Meningitis (meningococcal diseases) is characterized by inflammation of the protective lining (meninges) present around the brain and spinal cord. It can be classified into infectious and non-infectious meningitis. Based on the types of organism, infectious meningitis is sub-divided into bacterial meningitis, viral meningitis, fungal meningitis, and parasitic meningitis. Bacterial meningitis occurs due to bacterial species such as hemophilus influenzae, listeria monocytogenes, neisseria meningitidis, and streptococcus pneumoniae.

Technavio’s analysts forecast the global meningococcal vaccines market to grow at a CAGR of 13.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global meningococcal vaccines market for 2016-2020. To calculate the market size, the report considers the the report considers the revenue generated from the sales of vaccines used to prevent meningococcal infections.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Meningococcal Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GSK
  • Pfizer
  • Sanofi
Other prominent vendors
  • Beijing Minhai Biotechnology
  • Bio Med
  • Hualan Biological Engineering
  • Imunoloski Zavod
  • JN International Medical
  • Nuron Biotech
  • Serum Institute of India
  • Vacunas Finlay SA
  • Merck
  • GlycoVaxyn
  • Baxter
Market driver
  • Designated as a traveller’s vaccine
  • For a full, detailed list, view our report
Market challenge
  • High cost associated with vaccine development
  • For a full, detailed list, view our report
Market trend
  • Increase in strategic alliances and M&A
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Meningococcal Vaccines Market 2016-2020

Technavio recognizes the following companies as the key players in the global meningococcal vaccines market: GSK, Sanofi, and Pfizer.

Other Prominent Vendors in the market are Beijing Minhai Biotechnology, Bio Med, Hualan Biological Engineering, Imunoloski Zavod, JN International Medical, Nuron Biotech, Serum Institute of India, Vacunas Finlay, Merck, GlycoVaxyn, and Baxter.

Commenting on the report, an analyst from Technavio’s team said that the availability of combination vaccines is one of the key trends aiding to the growth of this market. Bacterial meningitis is caused by bacteria such as Haemophilus influenzae type B, meningococci, and pneumococci. Combination vaccines for meningitis target multiple causative agents, thereby preventing meningitis caused by these agents. For instance, Menhibrix is approved to prevent invasive meningococcal disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y. Thus, combination vaccines eliminate the need to administer individual vaccines. The lower the number of injections administered, the lower the frequency of injection site reactions, such as pain, increasing patient compliance. Increased compliance results in effective prevention of the disease. Combination vaccines also decrease the packaging and transportation expenditure associated with multiple individual vaccines. Collectively, these factors decrease the development and marketing costs of the vaccine and increase the market revenue by effective prevention of the disease.

According to the report, the increase in awareness about vaccination and immunization programs will lead to the growth of this market. The WHO conducted a program in over 180 countries in 2013 under the slogan 'Protect your world - get vaccinated'. In 2015, the organization celebrated the European Immunization Week from April 22nd-26th. Every year, the last week of April is observed as the World Immunization Week as per the WHO mandate. In the US, the Association of American Physicians (AAP) and the National Institute of Agricultural Marketing (NIAM) helped increase vaccination coverage in the region. The Amanda Young Foundation is dedicated to reducing the number of deaths from meningococcal disease in Western Australia by organizing activities such as summits and fundraising events to raise awareness about the disease. The foundation also provides funds to support new and ongoing research on the disease.

Further, the report states that vaccine storage and handling issues is one of the major challenges, decreasing the sales of the vaccine in countries with poor affordability. Vaccines require cold conditions to stay efficacious and are likely to lose their potency if the temperature drops below 35.6 degrees Fahrenheit or goes above 46.4 degrees Fahrenheit. Inadequately stored vaccines lose their efficacy and can cause increased local reactions. Though loss of effectiveness is irreversible, it leads to wastage of vaccine and resources. Thus, the temperature should be maintained at every step of the distribution chain to ensure the supply of potent vaccines. Cold storage requires special machinery and care, which increases the market price of vaccines.

Companies Mentioned

GSK, Sanofi, Pfizer, Beijing Minhai Biotechnology, Bio Med, Hualan Biological Engineering, Imunoloski Zavod, JN International Medical, Nuron Biotech, Serum Institute of India, Vacunas Finlay, Merck, GlycoVaxyn, Baxter.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Key buying criteria
      • Table Key buying criteria for meningococcal vaccines
  • Overview of vaccines
    • Understanding Meningococcal disease
      • Table Distribution of meningococcal bacterial strains
      • Table Distribution of meningococcal bacterial strains in US
      • Table Distribution of meningococcal bacterial strains UK
    • Causes of meningococcal diseases
      • Table Different type of bacterial causes of meningitis
    • Signs and symptoms
    • Epidemiology
    • Vaccine approval process
      • Table Requirements for a BLA submission
      • Table Different types of development necessary to reach vaccine licensing stage
      • Table Vaccine development process over a period of up to 15 years at a cost of up to $1 billion
      • Table Regulatory testing of licensed vaccines
      • Table Pediatric/VFC meningococcal vaccine price list 2015
      • Table Price of adult meningococcal vaccine 2015
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global meningococcal vaccines market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by composition
    • Table Global meningococcal vaccines market segmentation by composition
    • Mono vaccines
    • Combination vaccines
      • Table Global meningococcal vaccines market by composition 2015
  • Geographical segmentation
    • Global meningococcal vaccines market by geographical segmentation 2015-2020
      • Table Global meningococcal vaccines market by geography 2015
      • Table Global meningococcal vaccines market revenue by geography 2015-2020 ($ millions)
      • Table Percentage share of meningococcal vaccines market by geography 2015-2020
      • Table Global meningococcal vaccines market: YoY revenue and growth based on geography 2015-2020 ($ millions)
    • Meningococcal vaccines market in Americas
      • Table Meningococcal vaccines market in Americas 2015-2020 ($ billions)
      • Table Meningococcal vaccines market in America by country 2015
    • Meningococcal vaccines market in US
      • Table Meningococcal vaccines market in US 2015-2020 ($ billions)
    • Meningococcal vaccines market in the Brazil
      • Table Meningococcal vaccines market in Brazil 2015-2020 ($ millions)
    • Meningococcal vaccines market in EMEA
      • Table Meningococcal vaccines market in EMEA 2015-2020 ($ millions)
      • Table Meningococcal vaccines market in EMEA by country 2015
    • Meningococcal vaccines market in Europe
      • Table Meningococcal vaccines market in Europe 2015-2020 ($ millions)
    • Meningococcal vaccines market in APAC
      • Table Meningococcal vaccines market in APAC 2015-2020 ($ millions)
      • Table Meningococcal vaccines market in APAC by country 2015
    • Meningococcal vaccines market in Australia
      • Table Meningococcal vaccines market in Australia 2015-2020 ($ millions)
  • Market drivers
    • Increase in awareness about vaccination and immunization programs
    • Designated as a traveler's vaccine
    • Inclusion in national immunization schedule
    • Threat of bioterrorism
    • Additional age group approval
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Vaccine storage and handling issues
      • Table A typical cold chain process
    • High cost associated with vaccine development
    • Stringent regulations
    • Emergence of local players
    • Adverse effects
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Availability of combination vaccines
    • Increase in strategic alliances and M&A
      • Table Overview of major vaccine related acquisitions (2005-2012)
    • Focus on emerging markets
    • Public-private initiatives
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2015
      • Table Market share analysis of global meningococcal vaccines market 2015
    • Sanofi
      • Table Sanofi: YoY revenue growth of Meningitis/Pneumonia vaccines 2013-2015 ($ millions)
      • Table Geographical segmentation of meningitis/pneumococcal vaccines by revenue 2015
      • Table Sanofi: YoY revenue growth of Menactra 2013-2015 ($ millions)
      • Table Geographical segmentation of Menomune by revenue 2015
      • Table Key takeaways
    • GlaxoSmithKline (GSK)
      • Table Geographical segmentation of Bexsero by revenue 2015
      • Table Geographical segmentation of Menveo by revenue 2015
      • Table Key takeaways
    • Pfizer
      • Table Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report